This is unpublished
Advancing Actionable Cardiovascular Science and Clinical Care for Our Cancer Patients and Survivors
May 12, 2023
Bonnie Ky, MD, MSCE
Pinned
Grand Rounds Objectives
Upon completion of this program, attendees should be able to:
- We will define the current understanding of diagnosis and risk prediction in cancer therapy cardiotoxicity, with a specific focus on anthracyclines, HER2+, tyrosine kinase inhibitor, and radiation therapy.
- We will assess the role of imaging markers in cardio-oncology risk prediction and diagnosis.
- We will examine the role of biomarkers in cardio-oncology risk prediction and diagnosis.
Dr. Ky has requested that we do not record her presentation.
Bonnie Ky, MD, MSCE
Founders Associate Professor of Cardio-Oncology Division of Cardiovascular Medicine Senior Scholar, Center for Clinical Epidemiology and Biostatistics Director, Thalheimer Center for Cardio-Oncology Director, Penn Center for Quantitative Echocardiography
University of Pennsylvania
Founders Associate Professor of Cardio-Oncology Division of Cardiovascular Medicine Senior Scholar, Center for Clinical Epidemiology and Biostatistics Director, Thalheimer Center for Cardio-Oncology Director, Penn Center for Quantitative Echocardiography
University of Pennsylvania